Dunnett S B, Björklund A, Lindvall O
Nat Rev Neurosci. 2001 May;2(5):365-9. doi: 10.1038/35072572.
The results of the first double-blind placebo-controlled trial using grafts of embryonic tissue to treat Parkinson's disease have aroused widespread interest and debate about the future of cell replacement therapies. What are the key issues that need to be resolved and the directions in which this technology is likely to develop?
首个使用胚胎组织移植治疗帕金森病的双盲安慰剂对照试验结果引发了关于细胞替代疗法未来的广泛关注和争论。需要解决的关键问题有哪些,以及这项技术可能的发展方向是什么?